Evaluation of Subantimicrobial Dose Doxycycline Effects on Dental Implant Osseointegration in Type II Diabetic Patients

Document Type : Original Article

Authors

1 Associate Lecturer of Oral Medicine, Periodontology, Oral diagnosis and Radiology Department. Faculty of Dental Medicine for Girls. Al-Azhar University.

2 Professor of Oral Medicine, Periodontology, Oral diagnosis and Radiology Department, Vice- Dean for Postgraduate Studies. Faculty of Dental Medicine for Girls. Al-Azhar University.

3 Professor of Bio-Chemistry. Faculty of Medicine. Cairo University.

4 Associate Professor of Oral Medicine, Periodontology, Oral diagnosis and Radiology, Department. Faculty of Dental Medicine for Girls. Al-Azhar University.

Abstract

Objective
: The present study was carried out to compare radiographic outcomes of dental implant in type II diabetic patients with or without adjunctive administration of subantimicrobial dose doxycycline.
 
Subjects and Methods : This study included 20 patients with controlled type II diabetes mellitus of both genders, their age ranged from 40-48years.The study groups were designed in two groups, test group treated with dental implant with systemic administration of subantimicrobial dose doxycycline(SDD) for twice per day for 3 months and control group received dental implant alone.
 
Results: Regarding radiographic marginal bone levels measurements; in both groups the mean marginal bone loss increased by time, with significant difference between both groups where the test group (SDD received group) showed the lower marginal bone loss values. In both groups, bone density measurements increased by time, with significant percentage change recorded for test group (SDD received group) 55.22% while control group recorded 17.40% from base line values.
Conclusions:
The use of sub-antimicrobial dose doxycycline with dental implants in type II diabetic patients was effective as an adjunctive host modulatory drug. Systemic administration of subantimicrobial dose doxycycline with dental implants in type II diabetic patients resulted in greater increase in bone density and less marginal bone loss thus subantimicrobial dose doxycycline can enhance the osseointegration of dental implants.

Keywords

Main Subjects

References

1. Javed F, Romanos GE. Impact of diabetes mellitus and
glycemic control on the osseointegration of dental implants:
a systematic literature review. J Periodontol. 2009;
80:1719–1730.
2. Preeti AK, Manish K. Rupal J. Shah. Rehabilitative
Considerations for Dental Implantsin the Diabetic Patient.
J Indian Prostho dont Soc 13:175–183.
3. Preshaw PM. Host response modulation in periodontics.
Periodontology 2000. 2008; 48: 92-110.
4. Isoda K, Ayukawa Y, Tsukiyama Y, Sogo M, Matsushita
Y, Koyano K. Relationship between the bone densities estimated
by cone-beam computed tomography and the primary
stability of dental implants. Clin Oral Implants Res
2012; 23:832-836.
5. González-Martín O, Lee EA, Veltri M: CBCT fractal dimension
changes at the apex of immediate implants placed
using undersized drilling. Clin. Oral Implants Res 2012;
23: 954–95.
6. Hsu JT, Chang HW, Huang HL, Yu JH, Li YF, Tu MG:
Bone density changes around teeth during orthodontic
treatment. Clin Oral Investig 2011; 15:511-519
7.
 
Monje A, Monje F, Gonzalez-Garcı R, GalindoMoreno P,
Rodriguez-Salvanes F, Wang HL. Comparison between
microcomputed tomography and cone-beam computed
tomography radiologic bone to assess atrophic posterior
maxilla density and microarchitecture. Clin Oral Implants
Res 2014; 25: 723-728.
8. Hasan I, Dominiak M, Blaszczyszyn A, Bourauel C,
Gedrange T, Heinemann F. Radiographic evaluation of
bone density around immediately loaded implants. Ann
Anat 2015; 199:52-57.
9. Kholsa S. Minireview: the Opg/Rankl/Rank system.
Endocrinology 2001; 142: 5050–5055.
10. Abramson, J. H. The Cornell medical index as an epidemiological
tool, Am J Pub H and the Nat H 1966; 56:
287–298.
11. Caton J, Ryan ME. Clinical studies on the management of
periodontal diseases utilizing subantimicrobial dose doxycycline
(SDD). Pharmacol Res .2011; 63: 114-120.
12. Busenlechner D, Furhauser R, Haas R, Watzek G, Mailath
G, Pommer B. Long-term implant success at the Academy
for Oral Implantology: 8-year follow-up and risk factor
analysis. J Periodontal Implant Sci 2014; 44:102–8.
13.
 
Lambert P, Morris H, Ochi S: The influence of 0.12%
chlorhexidine digluconate rinses on the incidence of infectious
complications and implant success. J Oral Maxillofac
Surg 1997; 55:25-30.
14. Yassir Elkhidir, Sun Wei, Li Suyang, Mengqing Xie and
Cheng Yang. Feasibility of CBCT in Evaluating Bone
Density of Dental Implant Placement Sites. RRJDS. 2017;
5:87-91
15
Schwartz A. Diabetes mellitus: does it affect bone? CTI
2003; 73:515-9.
16. Oates T, Huynh-Ba G, Vargas A, Alexander P, Feine J. A
critical review of diabetes, glycemic control, and dental
implant therapy. Clin Oral Implants Res 2013; 24:117-27.
17. Olson JW, Shernoff AF, Tarlow JL, Colwell JA, Scheetz
JP, Bingham SF. Dental endosseous implant assessments
in a type 2 diabetic population: A prospective study. Int J
Oral Maxillofac Implants 2000; 15:811-818.
18. Peled M, Ardekian L, Tagger-Green N, Gutmacher Z,
Machtei EE. Dental implants in patients with type 2
diabetes mellitus: A clinical study. Implant Dent 2003;
12:116-122.
19. Casap N, Nimri S, Ziv E, Sela J, Samuni Y. Type 2 diabetes
has minimal effect on osseointegration of titanium
implants in Psammomys obesus. Clin Oral Implants Res
2008; 19:458-64.
20.
 
Balshi SF, Wolfinger GJ, Balshi TJ. An examination of
immediately loaded dental implant stability in the diabetic
patient using resonance frequency analysis (RFA).
Quintessence Int 2007; 38:271-9.
21. Tawil G, Younan R, Azar P, Sleilati G. Conventional and
advanced implant treatment in the type II diabetic patient:
surgical protocol and long-term clinical results. Int J Oral
Maxillofac Implants 2008; 23:744–52.
22. Morris HF, Ochi S, Winkler S. Implant survival in patients
with type 2 diabetes. Ann Periodontol 2000; 5:157-65.
23. Mccracken MS, Aponte-Wesson R, Chavali R, Lemons
JE McCracken. Bone associated with implants in diabetic
and insulin-treated rats. Clin Oral Implants Res 2006; 17:
495-500.
24. Hasegawa H, Ozawa S, Hashimoto K, Takeichi T, Ogawa T.
Type 2 diabetes impairs implant osseointegration capacity
in rats. Int J Oral Maxillofac Implants 2008; 23:237-246.
25. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host
modulation with antiproteinase, anti- inflammatory, and
bone-sparing agents. A systematic review. Ann Periodontol
2003; 8:12-37.
26. Preshaw PM, Hefti AF, Novak MJ. Subantimicrobial
dose doxycycline enhances the efficacy of scaling and
root planing in chronic periodontitis: a multicenter trial. J
Periodontol 2004;75:1068-76.
27. Khoury SB, Thomas L, Walters JD, Sheridan JF,
Leblebicioglu B. Early wound healing following one-stage
dental implant placement with and without antibiotic prophylaxis:
a pilot study. J Periodontol 2008; 79:1904–1912.
28. Alissa R, Sakka S, Oliver R, Horner K, Esposito M,
Worthington HV, Coulthard P. Influence of ibuprofen
on bone healing around dental implants: a randomized
double-blind placebo controlled clinical study. Eur J Oral
Implantol 2009; 2:185–199.
29. Waasdorp JA, Evian CI, Mandracchia M. Immediate
placement of implants into infected sites: a systematic
review of the literature. J. Periodontol 2010; 81:801–806.
30.
 
Barunawarty Y. Assessment of the increased calcification
of jaw bone with CT-Scan after dental implant placement.
Imaging Sci Dent 2011; 41: 59- 62.
31. Golub L, Lee H-M, Greenwald R, Ryan M, Sorsa T, Salo
T. A matrix metalloproteinase inhibitor reduces bone-type
collagen degradation fragments and specific collagenases
in gingival crevicular fluid during adult periodontitis. IR
1997; 46:310-9.
32. Gomes PS, Fernandes MH. Effect of therapeutic levels
of doxycycline and minocycline in the proliferation and
differentiation of human bone marrow osteoblastic cells.
AOB 2007; 52:251-9.
33. Almazin SM, Dziak R, Andreana S. The effect of
doxycycline hyclate, chlorhexidine gluconate, and
minocycline hydrochloride on osteoblastic proliferation
and differentiation in vitro. J Periodontol 2009; 80: 999–
1005.
34. Eglence A, Colterjohn N, Duivenvoorden WC, Ghert M,
Singh G. Effect of bone morphogenetic protein-2 and
doxycycline on the differentiation of osteoprogenitors
from human femoral bone. Open Bone J. 2009; 1:1-7.
35. Shahabooei M, Razavi SM, Minaiyan M. A
histomorphometric study of the effect of doxycycline and
erythromycin on bone formation in dental alveolar socket
of rat. Adv Biomed Res 2015; 4:71.
36. Lin Ding, Peng Zhang, Xin Wang, Jia Hao, Kazuhiro Aoki,
Shinji Kuroda, Shohei Kasugai Effect of doxycyclinetreated
hydroxyapatite surface on bone apposition: A
histomophometric study in murine maxillae. DMJ 2017;
11: 1- 9.
37. Yiming Liu, Jing Hu, Biao Liu, Xiliang Jiang, Yunfeng
Li. peri-implant bone mass and improved trabecular
microarchitecture. The effect of osteoprotegerin on
implant osseointegration in ovariectomized rats. Arch Med
Sci 2017; 13, 2: 489–495.
38. Sunitha RV, Ramakrishnan T, Kumar S, Emmadi P. Soft
tissue preservation and crestal bone loss around singletooth
implants. J Oral Implantol 2008; 34:223-229.
39. PriyanKa Boora, Manu rathee, MohaneeSh Bhoria. Effect
of Platelet Rich Fibrin on Peri- implant Soft Tissue and
Crestal Bone. JCDR 2015; 9: 18-21.
40. Cavallaro JS Jr. Implant survival and radiographic analysis
of proximal bone levels surrounding a contemporary
dental implant. Implant Dent 2011; 20: 146-5.
41. Lee DW, Choi YS, Park KH, Kim CS, Moon IS. Effect of
microthread on the maintenance of marginal bone level:
a 3-year prospective study. Clin Oral Implants Res 2007;
18:465-70.
42. Cochran DL, Nummikoski V, Schoolfeld JD, Jones AA,
Oates TW. A prospective multicenter 5-year radiographic
evaluation of crestal bone levels over time in 596 dental
implants placed in 192 patients. J Periodontol 2009;
80:725-33.
43. Choi DH, Moon IS. Effects of sub-antimicrobial dose
doxycycline therapy on crevicular fluid MMP-8 and
gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic
periodontitis. J Periodont Res 2004; 39: 20-26.
44. Kinugawa S, Koide M, Kobayashi Y. Tetracyclines convert
the osteoclasticdifferentiation pathway of progenitor cells
to produce dendritic cell-like cells. J Immunol 2012; 188:
1772–1781.
45. Nurdan O, Ceren G. Chemical inhibition of matrix
metalloproteinases for periodontal treatment. Antiinflamm
Antiallergy Agents Med Chem 2015; 2: 21-26.
46. Bezerra MM, Brito GA, Ribeiro RA. Low-dose
doxycycline prevents inflammatory bone resorption in
rats. Braz J Med Biol Res 2002; 35: 613–616.
47. Holmes SG, Still K, Buttle DJ, Bishop NJ. Chemically
modified tetracyclines act through multiple mechanisms
directly on osteoclast precursors. Bone 2004; 35:471-8.
48. Zhang C, Tang TT, Ren WP. Inhibiting wear particlesinduced
osteolysis with doxycycline. Acta Pharmacol Sin
2007; 28:1603–1610.
.

Files

Share

How to cite

Statistics